NY Times Prescription Blog

Prescriptions

Making Sense of the Health Care Debate



A Note to Readers of This Blog

The Times is discontinuing the Prescriptions blog.

Author: By The New York Times
Posted: February 24, 2012, 6:36 pm



Drug Costs Pose Smaller Financial Burden Amid Generic Boom

Americans are using more prescription drugs, but the financial burden of those drugs on families is falling, according to a new study. A big reason is the rise of generics.

Author: By Bruce Japsen
Posted: February 8, 2012, 9:00 pm



Drug Makers Dial Down TV Advertising

Pharmaceutical companies have cut spending on television advertising by 20 percent over the last five years, according to a Nielsen study. Analysts expect drug advertising to continue to fall as more brand-name drugs face generic competition.

Author: By Bruce Japsen
Posted: February 2, 2012, 11:27 pm



F.D.A. Approves Drug for an Advanced Skin Cancer

The drug, Erivedge, made by Genentech, was approved for adults with basal cell carcinoma that has spread elsewhere in the body or those who are not candidates for surgery or radiation.

Author: By Andrew Pollack
Posted: January 30, 2012, 8:44 pm



Despite Generic Rivals, Branded Drugs Still Sell Well

Drug companies are finding lucrative foreign markets for their brand-name drugs after patents expire in the United States and unleash generic competition.

Author: By Bruce Japsen
Posted: January 25, 2012, 9:36 pm



Doctors Refer More Patients to Specialists

A new study finds that primary care doctors are referring patients to other doctors at double the rate of a decade ago. The reasons are unclear but the researchers say the practice is driving up health care costs.

Author: By Reed Abelson
Posted: January 23, 2012, 9:16 pm



F.D.A. Delays Approval of New Diabetes Drug

Federal drug regulators are seeking more data from AstraZeneca and Bristol-Myers Squibb before deciding whether to approve dapagliflozin, a new drug aimed at Type 2 diabetes.

Author: By Andrew Pollack
Posted: January 19, 2012, 7:17 pm



New Questions Raised About Tamiflu’s Effectiveness

A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.

Author: By Andrew Pollack
Posted: January 18, 2012, 12:01 am



More Health Clinics Pop Up Inside Retailers

The number of medical clinics inside retail stores is expected to boom, in part because of incentives under the new federal health care law. Chains like Safeway and Walmart already have big expansion plans.

Author: By Bruce Japsen
Posted: January 9, 2012, 11:00 pm



Walgreen Girds for Fight Over Customers

Walgreen to introduce a national plan it hopes will minimize customer disruption from its contract battle with its pharmacy benefits manager, Express Scripts.

Author: By Bruce Japsen
Posted: December 30, 2011, 6:19 pm



 

Categories

Stay Connected